J Med Microbiol 55 (2006), 905-911; DOI: 10.1099/jmm.0.46580-0
© 2006 Society for General Microbiology
ISSN 1473-5644
Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein–Barr virus (EBV) in gastric epithelial cells latently infected with EBV
Junko Minoura-Etoh1,
Kazuyo Gotoh1,
Ryugo Sato2,
Masao Ogata2,
Naomi Kaku3,
Toshio Fujioka4 and
Akira Nishizono1
Microbiology1 , Second Internal Medicine2 , Oral-Maxillary Surgery3 and General Medicine4 , Department of Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan
Correspondence
Akira Nishizono
a24zono{at}med.oita-u.ac.jp
Received 16 February 2006
Accepted 14 March 2006
To investigate the possibility of an interaction between two ubiquitous human pathogens, Helicobacter pylori and Epstein–Barr virus (EBV), the effect of monochloramine (NH2Cl), locally produced by H. pylori infection, on gastric epithelium latently infected with EBV was examined, by assessing the induction of EBV lytic infection. AGS cells harbouring latently infected EBV were used as the indicator of lytic change caused by NH2Cl treatment. Lytic infection, determined by morphological change and EA-D antigen expression, occurred immediately after treatment with in vitro-synthesized NH2Cl. Analysis of EBV infection in human gastric tissue revealed that out of 48 H. pylori-positive patients, 24 were positive for EBER-1, and 18 and 13 were positive for EBNA1 and LMP-1 antigen, respectively. The results suggest that H. pylori-associated NH2Cl induces EBV lytic conversion in gastric epithelium latently infected with EBV.
Abbreviations: EBV, Epstein–Barr virus; FACS, fluorescence-activated cell sorting; FBS, fetal bovine serum; ISH, in situ hybridization; TPA, 12-O-tetradecanoylphorbol-13-acetate.
 |
INTRODUCTION
|
|---|
Chronic microbial infections induce malignant tumours in humans and animals. It is well known that H. pylori infection is closely associated with gastric mucosal atrophy, intestinal metaplasia and subsequent well-differentiated adenocarcinoma of the stomach via a cause–effect relationship between microbial infection and gastric carcinogenesis (Nomura et al., 1991; Parsonnet et al., 1991). Epstein–Barr virus (EBV) is a ubiquitous herpes virus that is well documented to be causally associated with various malignant tumours, including Burkitt's lymphoma, nasopharyngeal carcinoma, and B-cell lymphoma in immunodeficient individuals, and is also known to be an important aetiologic agent of gastric carcinoma, as is H. pylori (Rickinson & Kieff, 2001). Approximately 7 % of gastric carcinomas are reported to be monoclonal proliferations of gastric epithelial cells infected by EBV (Imai et al., 1994), and lymphoepithelioma-like carcinoma of the stomach is the most prevalent phenotype in EBV-infected gastric carcinoma (Wu et al., 2000). All EBV-carrying gastric carcinomas have been reported to have individual single clonotypes of EBV DNA, as determined by terminal repeat (TR) analysis and the presence of EBV-encoded small RNA1 (EBER-1) (Fukayama et al., 1994).
EBV preferentially infects B lymphocytes via the EBV receptor (CD21), and the major envelope protein of EBV gp350/220 is a ligand for CD21 (Kieff & Rickinson, 2001). Although EBV primarily infects the mucosal epithelium of the oropharynx, such epithelial cells do not possess CD21 molecules on their surface, unlike B cells (Janz et al., 2000). The mechanisms of the primary viral infection of epithelium, especially gastric cells, are not understood. According to a recent report, EBV infections are detected in non-carcinoma gastric epithelium characterized by chronic atrophic gastritis accompanied by intestinal metaplasia (Yanai et al., 1997). Whether such gastric epithelium latently infected with EBV functions as the progenitor of gastric carcinoma or as a producer of progeny virus is not understood. Although the EBV genome is latent in B cells and oropharyngeal/gastric epithelial cells in the carrier state, reactivation of the EBV genome occurs after various stimuli, whereby it enters into the viral lytic cycle (Kieff & Rickinson, 2001). A number of different stimuli or agents in vitro have been shown to trigger the switch from the latent infection state into the lytic infection. These include halogenated pyrimidines, nutrient starvation, phorbol esters, calcium ionophores, transforming growth factor beta 1 (TGF-ß1), n-butyrate, histone deacetylase inhibitors, azacytidine, and cross-linking of surface immunoglobulin (Gradoville et al., 2002). Of these lytic-infection-inducing stimuli, several are capable of leading to cell cycle arrest or cell death (Kudoh et al., 2003).
H. pylori-colonized gastric mucosa is characterized by dominant accumulation of neutrophils and lymphocytes in the infected gastric mucosa; activated neutrophils generate O2.– and H2O2 (Morris & Nicholson,1987). Myeloperoxidase in neutrophils catalyses the oxidation of chloride by H2O2 to yield hypochlorous acid (HOCl). The interaction between H. pylori-derived NH3 and HOCl produces monochloramine (NH2Cl), which is reactive and toxic, and leads to gastric mucosal cell injury via destruction of DNA double strands and chromatin condensation because of its lipophilic properties and low molecular mass (Murakami et al., 1995; Sato et al., 1999; Suzuki et al.,1992). In addition, NH2Cl is known to induce detachment of various types of cells (fibroblasts, epithelial cells and endothelial cells) from culture dishes, with concomitant cell shrinkage (Nakamura et al., 1995).
Thus, both H. pylori and EBV infect the human stomach, and therefore may have a synergistic relationship or some other form of impact on each other. The aim of the present study was to examine whether H. pylori induces reactivation of the EBV lytic cycle in the human gastric epithelium which these two pathogens commonly colonize, via a cell damage process induced by NH2Cl production.
|
METHODS
|
|---|
Cell culture.
AGS-neo cells were transfected with recombinant EBV containing the neomycin resistance (Neor) gene at the BZLF1 site of EBV DNA, which is non-essential for infection and replication in AGS cells. The original AGS cell line was a gastric carcinoma cell line derived from a signet ring cell carcinoma of the stomach. This cell line was kindly provided by Professor K. Takada and Dr H. Yoshiyama, Hokkaido University School of Medicine (Yoshiyama et al., 1997). Cells were subcultured twice a week (5x104 cells ml–1) in F-12 (HAM) Nutrient Mixture medium (Gibco) supplemented with 10 % (v/v) non-heat-inactivated fetal bovine serum (FBS) (Equitech-bio, ICN Pharmaceuticals), 100 U penicillin ml–1, 100 µg streptomycin ml–1 and 500 µg geneticin ml–1. B95-8 and Raji cells were cultured in RPMI1640 medium (Gibco) supplemented with 10 % (v/v) heat-inactivated FBS, 100 U penicillin ml–1 and 100 µg streptomycin ml–1.
Preparation of NH2Cl in vitro.
In vitro synthesis of NH2Cl was carried out according to the method of Grisham et al. (1990). Briefly, NH2Cl was synthesized by adding NaOCl to a solution of ammonium chloride in 0.05 M phosphate buffer (pH 8.0). The concentration of NH2Cl was determined assuming a molar extinction coefficient of 429 at 242 nm.
Detection of EBV EA-D by Western blotting and immunofluorescence microscopy.
Western blotting was performed as described previously (Sumie et al., 2001). Briefly, the cell lysate was subjected to SDS-12.5 % PAGE and the resolved proteins were electroblotted onto a PVDF membrane. The blotted membrane was reacted with 1 : 5000-diluted mouse anti-EBV EA-D-p52/50 monoclonal antibody (R3, Chemicon International) and subsequently reacted with 1 : 5000-diluted peroxidase-conjugated goat anti-mouse IgG. The membrane was treated with the ECL kit-WB detection system (Amersham) and exposed to X-ray film. Monolayer-cultured AGS-neo cells were treated with 1 µg ml–1 12-O-tetradecanoylphorbol-13-acetate (TPA; Sigma) in six-well plates and cultured. After incubation for 2 days, cells were collected and Western blotting was carried out to detect EBV EA-D. Similarly, EBV EA-D was detected after stimulation of AGS-neo cells by in vitro-synthesized NH2Cl. NH2Cl was added at concentrations of 2, 20, 200 and 2000 µM to AGS-neo monolayers in six-well plates. After incubation for 5 min, the cells were collected, and Western blotting was carried out. Alternatively, NH2Cl was added to AGS-neo monolayers in six-well plates at a concentration of 100 µM. After incubation for 2.5, 5, 7.5, 10, 15, 20, 30, 40, 50, 60 or 70 min, the cells were collected and Western blotting was performed. The cells were cultured for 48 h at 37 °C under the conditions described above. Then, 100 µM NH2Cl or 100 µM NH2Cl combined with 20 mM methionine (Sigma), which is an NH2Cl scavenger, was added prior to immunofluorescent staining for EA-D.
Immunofluorescent staining for EA-D was carried out by indirect immunofluorescence with 1 : 40-diluted mouse anti-EBV EA-D-p52/50 monoclonal antibody, as described above, followed by FITC-conjugated anti-mouse IgG (Cappel) as the secondary antibody.
Flow cytometry.
The expression of EBV-associated antigen, EBNA1, by AGS-neo cells, and of EA-D by Raji and B95-8 cells, was also measured by indirect immunofluorescent flow cytometric analysis using a FACSCalibur (BD Immunocytometry Systems) flow cytometer and CellQuest software. Prior to reaction with the primary antibody, cells were treated with permeabilization reagent using IntraPrep Reagent (Immunotech) according to the manufacturer's procedures, and then 1x105 cells were incubated on ice for 1 h with 1 : 40-diluted anti-EBNA1 rat monoclonal antibody (2B4-1; Dako) and anti-EBV EA-D-p52/50 mouse monoclonal antibody. FITC-conjugated anti-mouse (1 : 50) monoclonal antibody was used as the secondary antibody.
Gastric biopsy specimens.
Seventy-eight gastric biopsy specimens were obtained from 78 patients who presented with gastrointestinal symptoms and were encouraged to undergo stomach biopsy at Oita University Hospital. All patients were examined regarding H. pylori infection status, which was determined by bacterial culture, histology, and urea breath test. Forty-eight patients were positive for H. pylori infection and the remaining 30 patients were negative. The specimens were fixed in formalin, embedded in paraffin wax, and used for in situ hybridization (ISH) and immunostaining. Informed consent was obtained from all patients before study participation. The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Oita University.
Immunohistochemistry for EBNA1, LMP-1 and H. pylori, and ISH for EBER-1.
Anti-EBNA1 rat monoclonal, anti-LMP-1 mouse monoclonal (S-12, Dako) and anti-H. pylori rabbit polyclonal (B0471, Dako) antibodies were used for the identification of the latent infection state of EBV and the localization of H. pylori. A standard immunoperoxidase staining procedure (Vectastain ABC kit, Vector Laboratories) was used for the antigen detection. EBER-1 was detected with a digoxigenin-labelled 30-base oligomer probe (Research Genetics), using procedures described elsewhere (Yanai et al., 1997). Paraffin-embedded sections (5 µm thick) of biopsy specimens were deparaffinized, rehydrated, pre-digested with Pronase and pre-hybridized, and then hybridized overnight at 37 °C. After washing with 0.5x SSC, hybridization was detected using an anti-digoxigenin antibody alkaline phosphatase conjugate (Boehringer Mannheim) according to the manufacturer's instructions. Confluent cultured AGS-neo cells in a chamber slide (Lab-Tek, Nalge Nunc) were fixed with cold acetone and subjected to a similar ISH technique for the detection of EBER-1.
|
RESULTS
|
|---|
Characterization of EBV infection status of AGS-neo cells in the resting state and after TPA treatment
The ISH assay demonstrated that EBER-1 was abundantly transcribed in all AGS-neo cells without any lytic stimuli (Fig. 1A
). Flow cytometry analysis revealed that AGS-neo cells showed apparent expression of EBNA1 in the resting state (Fig. 1B). The phorbol ester TPA is the most reproducible and widely used inducer of lytic EBV infection. The expression of EA-D antigen in AGS-neo cells was detected in the presence of TPA at a final concentration of 1 µg ml–1. After the treatment with TPA, AGS-neo cells that appeared to be detached from the culture flask (lane 2, Fig. 1C) showed stronger EA-D expression than adherent cells (lane 1, Fig. 1C).
View larger version (40K):
[in this window]
[in a new window]
|
Fig. 1. Characteristics of AGS-neo cells with respect to EBV latent infection and lytic conversion induced by TPA: in situ detection of EBER-1 expression in AGS-neo cells. Strongly positive reactions of EBER-1 were seen in AGS-neo cells by ISH (A) and the expression of EBNA1 antigen (white peak) was examined by FACS analysis (B). The grey peak shows theexpression of EBNA1 signal without primary antibody. Monolayer-cultured AGS-neo cells were treated with 1 µg TPA ml–1 in six-well plates, and cells were then collected separately after 2 days incubation. (C) Western blotting was carried out for the detection of EBV EA-D. Lane 1, cell lysate obtained from adherent AGS-neo cells treated with 1 mg TPA ml–1; lane2, lysate from detached AGS-neo cells treated with the same concentration of TPA; lane 3, lysate from AGS-neo cells withouttreatment with TPA.
|
|
Expression of EBV EA-D after NH2Cl treatment in vitro
Firstly, we determined whether or not in vitro synthesized NH2Cl could induce lytic infection in B-cell lines, namely B 95-8 and Raji cells, latently infected with EBV. As shown in Fig. 2(A, B), apparent deviations of EA-D expression in B 95-8 and Raji cells were observed in the presence of 100 µM NH2Cl. Although minimal increases were observed after 1 h of NH2Cl treatment, the degree of increase was clearer after 48 h of treatment.
View larger version (58K):
[in this window]
[in a new window]
|
Fig. 2. Effect of NH2Cl on EBV cells and AGS-neo cells. (A, B) Expression of EA-D antigen on the surface of Raji (A) and B95-8 (B) cells treated with NH2Cl: after 48 h, the bold line (white peak) shows the level of EA-D antigen in cells treated at a concentration of 100 µM NH2Cl and the thin line shows the level without NH2Cl treatment (grey peak). (C) NH2Cl was added at concentrations of 0, 2, 20, 200 and 2000 µM to AGS-neo monolayers placed in six-well plates. After incubation for 5 min, the cells were collected, and Western blotting was performed with anti-EBV EA-D p52/50 antibody (x5000) as the primary antibody. (D) NH2Cl was added at a concentration of 100 µM to AGS-neo monolayers in six-well plates. After incubation for 0, 2.5, 5, 7.5, 10, 15, 20, 30, 40, 50, 60 and 70 min, the cells were collected, and Western blotting was performed. EBV EA-D was detected within 2.5 min of stimulation with NH2Cl.
|
|
In order to investigate the induction of EBV lytic infection by NH2Cl produced by H. pylori infection in gastric mucosa, we studied the effect of in vitro NH2Cl on AGS-neo cells. Increased expression of EA-D was observed in a dose-dependent manner after the addition of in vitro-synthesized NH2Cl (Fig. 2C
). Such expression was detected as early as 2.5 min after the addition of NH2Cl, and was sustained for almost 60 min (Fig. 2D). More than 2 h treatment of AGS-neo cells with 100 µM NH2Cl caused a higher proportion of damaged cells, cell detachment and cell death.
Although confluent AGS-neo cells show an adherent and polygonal appearance (Fig. 3A), cell detachment (Fig. 3B) and EBV EA-D-positive cells (Fig. 3C) were observed following the addition of NH2Cl at 100 µM. The addition of methionine (20 mM), a well-known specific scavenger of NH2Cl, prior to the treatment with NH2Cl completely inhibited the detachment of cells from the bottom of the culture dish (Fig. 3D). Furthermore, the addition of methionine to NH2Cl-treated AGS-neo cells resulted in inhibition of not only the cell damage but also EA-D antigen expression (data not shown).
View larger version (109K):
[in this window]
[in a new window]
|
Fig. 3. NH2Cl induces morphological changes and EA-D expression in AGS-neo cells. Microscopic findings of the effect of NH2Cl on AGS-neo cells are shown. The cells were cultured for 48 h at 37 °C in F-12 (HAM) Nutrient Mixture medium supplemented with 10 % (v/v) non-heat-inactivated FBS, 100 U penicillin ml–1, 100 µg streptomycin ml–1 and 500 µg geneticin ml–1 (A). (B) NH2Cl at 100 µM was added to the confluent AGS-neo cells and the cells were incubated for 60 min. Most cells were round, shrunken and detached from the bottom of the flask. Such damaged cells showed expression of EA-D antigen (C). When 20 mM methionine was added prior to treatment with 100 µM NH2Cl, the cells completely retained adhesion to the culture dishes (D).
|
|
Immunohistochemistry of EBNA1, LMP-1 and H. pylori antigen expression and ISH for EBER-1 in gastric biopsy specimens
Next we explored whether EBV-infected gastric epithelium could interact with H. pylori, and also examined the associated inflammatory changes in human specimens. Of 48 H. pylori-positive patients, 24 were positive for EBER-1, as determined by ISH (Table 1). In comparison, only two of 30 H. pylori-negative patients were positive for EBER-1 (Table 1). As shown in Fig. 4(A), the EBER-1 signal was localized in a relatively deep area of gastric mucosal layer, and goblet cell metaplasia was occasionally observed close to EBER-1-positive cells. Immunohistochemical analyses using anti-EBNA1 and anti-LMP-1 monoclonal antibodies revealed that among 48 H. pylori-positive patients, 18 and 13 cases were positive for EBNA1 and LMP-1 antigen, respectively (Table 1 and Fig. 4B, C). Positive expression of latent antigen was also localized in relatively deeper areas of the gastric glands. Live H. pylori cells densely colonized the mucosal surface of the H. pylori-infected gastric tissue, but not the deeper area. Inflammatory reactions characterized by dense infiltration of neutrophils and lymphocytes were recognized in the interstitial area of the gastric mucosa (Fig. 4C).
View this table:
[in this window]
[in a new window]
|
Table 1. Incidence of EBV gene (EBER-1) and associated antigens (EBNA1 and LMP-1) by ISH and immunostaining in H. pylori-infected and -uninfected individuals
+, H. pylori infected; –, uninfected.
|
|
View larger version (53K):
[in this window]
[in a new window]
|
Fig. 4. Detection of EBV latent infection-associated antigens and H. pylori in gastric specimens colonized with H. pylori. (A) EBER-1 signals (closed arrow) were noted in a deep region of gastric glands with heavy goblet cell metaplasia. (B, C) H. pylori bacteria (open arrow) were observed on the surface of gastric epithelium. EBV latent antigen EBNA1 (B, closed arrow) and LMP-1 (C, closed arrow) showed positive reactions in the middle or lower layer of the gastric glandular region with inflammation. Bar, 0.4 mm.
|
|
|
DISCUSSION
|
|---|
Infection with EBV occurs in most individuals. EBV is associated with several forms of human neoplasm (Rickinson & Kieff, 2001) and is also known to be an important aetiologic agent of gastric carcinoma (Shibata & Weiss, 1992). EBV infection may cause gastric carcinoma in areas of damaged gastric tissue, which is also a well-known pathological consequence of H. pylori infection. Previous studies of mutual interactions between H. pylori and EBV in the human stomach show that the clinicopathological relationship in gastric carcinogenesis remains unclear (Wu et al., 2000; Shinohara et al., 1998). In the present study, we speculated that these two ubiquitous pathogens, H. pylori and EBV, have direct or indirect relevance to environmental changes in the infected host. We assumed that H. pylori or its products could affect the EBV life cycle, especially the viral reactivation process.
To date, the pathogenicity of H. pylori has been demonstrated in terms of epithelial damage, and in particular in terms of the association with gastric carcinogenesis. We demonstrated that half of the gastric biopsy specimens from H. pylori-infected individuals showed positive signals for EBER-1 (Table 1), and such cryptic EBV infection might be affected by H. pylori infection. Firstly, we hypothesized that intracellular signal modification by cagA injection into the AGS-neo cells via type IV secretion machinery might be responsible for the EBV reactivation process (Asahi et al., 2000; Higashi et al., 2002; Mimuro et al., 2002). However, the induction of EA-D antigen was observed at equal levels for H. pylori strains that possessed cagPAI and those that did not (data not shown). Therefore, other mechanisms may be involved in EBV reactivation in the AGS-neo cells. The neutrophil-derived membrane-permeating oxidant NH2Cl is known to induce detachment of cultured cells, concomitant with DNA damage (Suzuki et al., 1997, 1998), as well as morphological changes characteristic of those caused by dephosphorylation of p-Tyr and an increase in intracellular Ca2+ concentration (Nakamura et al., 1995). Mobilization of intracellular Ca2+ is closely correlated with the induction of ZEBRA protein, which is known to be the immediate early gene product encoded by BZLF1.
Reactivation of the EBV lytic programme in the epithelium, unlike in B lymphocytes, is not clearly understood (Faulkner et al., 2000). EBV BZLF1 protein is known to inhibit host-cell proliferation by causing cell-cycle arrest in G0/G1 in several epithelial tumour cell lines (Cayrol & Flemington, 1996; Rodriguez et al., 2001). After activation of the lytic programme by BZLF1 induction, B95-8 cells are arrested mainly around the G1/S boundary, and the progression from G1 to S phase, in which cellular DNA synthesis is inhibited, appears to favour viral lytic replication (Kudoh et al., 2003). Therefore, the virus replication/reactivation from the latent stage and the host intracellular environment are closely related. It may be considered that EBV makes rapid and strong attempts to survive or to preserve its genome information when the infected host cells are confronted with a crisis or death situation (Hoshikawa et al., 2002).
Our study indicates for the first time that the H. pylori-associated oxidant NH2Cl is able to induce the lytic conversion of latent EBV infection. Moreover, the switching of EBV from the latent to the lytic phase occurred very rapidly, which should enable the virus to survive or maintain the viral genome, because exposure to higher concentrations (>100 µM) of NH2Cl for over 2 h resulted in cell death (Nakamura et al., 1995), mediated by a ‘peeling off’ phenomenon characterized by marked morphological changes with cell detachment, ballooning and hypercontraction. We speculate that the expression of EA-D antigen in AGS-neo cells is closely associated with the morphological changes that occur during the EBV reactivation process. In a preliminary study, we found by fluorescence-activated cell sorting (FACS) analysis that the expression of Annexin V of AGS-neo cells increased immediately after treatment (within 2.5 min) with 100 µM NH2Cl, and whereas the proportion of viable cells in the presence of 100 µM NH2Cl was more than 90 % up to 2.5 min, the proportion decreased by more than 50 % after 60 min in the presence of the same concentration of NH2Cl (data not shown). Following the reactivation of the expression of EBV early gene products by H. pylori infection or NH2Cl treatment, progeny virus will be released from the AGS-neo cells. Supernatants from H. pylori-infected AGS-neo cells successfully transformed peripheral B lymphocytes and showed EBNA1 expression in their cytoplasm (data not shown). These observations are consistent with the hypothesis that EBV reactivation and newly synthesized viral production occur during H. pylori infection in the human stomach.
In conclusion, H. pylori-associated gastric inflammation induces the production of the oxidant NH2Cl, derived from infiltrating neutrophils, and this converts the latent EBV infection to infection with activation of the early gene, resulting in the induction of lytic EBV infection.
|
ACKNOWLEDGEMENTS
|
|---|
The authors gratefully acknowledge Professor Kenzo Takada and Dr Hironori Yoshiyama, Department of Virology, Cancer Institute, Hokkaido University School of Medicine, for providing AGS-neo cells. We thank Professor Takeshi Sairenji, Department of Biosignalling, School of Life Science, Faculty of Medicine, Tottori University, for helpful discussions and also thank Mr Shinji Yano and Kiyomi Ohno for excellent technical assistance.
|
REFERENCES
|
|---|
Asahi, M., Azuma, T., Ito, S. & 9 other authors (2000). Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191, 593–602.[Abstract/Free Full Text]
Cayrol, C. & Flemington, E. (1996). G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein–Barr virus transactivator Zta. J Biol Chem 271, 31799–31802.[Abstract/Free Full Text]
Faulkner, G. C., Krajewski, A. S. & Crawford, D. H. (2000). The ins and outs of EBV infection. Trends Microbiol 8, 185–189.[CrossRef][Medline]
Fukayama, M., Hayashi, Y., Iwasaki, Y. & 7 other authors (1994). Epstein–Barr virus-associated gastric carcinoma and Epstein–Barr virus infection of the stomach. Lab Invest 71, 73–81.[Medline]
Gradoville, L., Kwa, D., El-Guindy, A. & Miller, G. (2002). Protein kinase C-independent activation of the Epstein–Barr virus lytic cycle. J Virol 76, 5612–5626.[Abstract/Free Full Text]
Grisham, M. B., Gaginella, T. S., von Ritter, C., Tamai, H., Be, R. M. & Granger, D. N. (1990). Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 14, 531–542.[CrossRef][Medline]
Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M. & Hatakeyama, M. (2002). SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683–686.[Abstract/Free Full Text]
Hoshikawa, Y., Satoh, Y., Murakami, M., Maeta, M., Kaibara, N., Ito, H., Kurata, T. & Sairenji, T. (2002). Evidence of lytic infection of Epstein–Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol 66, 351–359.[CrossRef][Medline]
Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E. & Osato, T. (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein–Barr virus latent infection protein. Proc Natl Acad Sci U S A 91, 9131–9135.[Abstract/Free Full Text]
Janz, A., Oezel, M., Kurzeder, C., Mautner, J., Pich, D., Kost, M., Hammerschmidt, W. & Delecluse, H. J. (2000). Infectious Epstein–Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74, 10142–10152.[Abstract/Free Full Text]
Kieff, E. & Rickinson, A. B. (2001). Epstein–Barr virus. In Fields Virology, pp. 2511–2573. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
Kudoh, A., Fujita, M., Kiyono, T., Kuzushima, K., Sugaya, Y., Izuta, S., Nishiyama, Y. & Tsurumi, T. (2003). Reactivation of lytic replication from B cells latently infected with Epstein–Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77, 851–861.[CrossRef][Medline]
Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R. & Sasakawa, C. (2002). Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 10, 745–755.[CrossRef][Medline]
Morris, A. & Nicholson, G. (1987). Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 82, 192–199.[Medline]
Murakami, M., Asagoe, K., Dekigai, H., Kusaka, S., Saita, H. & Kita, T. (1995). Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage. Dig Dis Sci 40, 268–273.[CrossRef][Medline]
Nakamura, T. Y., Yamamoto, I., Nishitani, H., Matozaki, T., Suzuki, T., Wakabayashi, S., Shigekawa, M. & Goshima, K. (1995). Detachment of cultured cells from the substratum induced by the neutrophil-derived oxidant NH2Cl: synergistic role of phosphotyrosine and intracellular Ca2+ concentration. J Cell Biol 131, 509–524.[Abstract/Free Full Text]
Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I. & Blaser, M. J. (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325, 1132–1136.[Abstract]
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N. & Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325, 1127–1131.[Abstract]
Rickinson, A. B. & Kieff, E. (2001). Epstein–Barr virus. In Fields Virology, pp. 2575–2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
Rodriguez, A., Jung, E. J., Yin, Q., Cayrol, C. & Flemington, E. K. (2001). Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284, 159–169.[CrossRef][Medline]
Sato, K., Watanabe, S., Yoshizawa, T., Hirose, M., Murai, T. & Sato, N. (1999). Ammonia, hydrogen peroxide, and monochloramine retard gastric epithelial restoration in rabbit cultured cell model. Dig Dis Sci 44, 2429–2434.[CrossRef][Medline]
Shibata, D. & Weiss, L. M. (1992). Epstein–Barr virus-associated gastric adenocarcinoma. Am J Pathol 140, 769–774.[Abstract]
Shinohara, K., Miyazaki, K., Noda, N., Saitoh, D., Terada, M. & Wakasugi, H. (1998). Gastric diseases related to Helicobacter pylori and Epstein–Barr virus infection. Microbiol Immunol 42, 415–421.[Medline]
Sumie, A., Yamashiro, T., Nakashima, K., Nasu, M., Watanabe, M. & Nishizono, A. (2001). Comparison of genomic structures and antigenic reactivities of orthologous 29-kilodalton outer membrane proteins of Helicobacter pylori. Infect Immun 69, 6846–6852.[Abstract/Free Full Text]
Suzuki, M., Miura, S., Suematsu, M. & 7 other authors (1992). Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 263, G719–G725.[Medline]
Suzuki, H., Mori, M., Suzuki, M., Sakurai, K., Miura, S. & Ishii, H. (1997). Extensive DNA damage induced by monochloramine in gastric cells. Cancer Lett 115, 243–248.[CrossRef][Medline]
Suzuki, H., Seto, K., Mori, M., Suzuki, M., Miura, S. & Ishii, H. (1998). Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am J Physiol 275, G712–G716.[Medline]
Wu, M. S., Shun, C. T., Wu, C. C., Hsu, T. Y., Lin, M. T., Chang, M. C., Wang, H. P. & Lin, J. T. (2000). Epstein–Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 118, 1031–1038.[CrossRef][Medline]
Yanai, H., Takada, K., Shimizu, N., Mizugaki, Y., Tada, M. & Okita, K. (1997). Epstein–Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 183, 293–298.[CrossRef][Medline]
Yoshiyama, H., Imai, S., Shimizu, N. & Takada, K. (1997). Epstein–Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71, 5688–5691.[Abstract]
TOP
INTRODUCTION
METHODS
